Caribou Biosciences Inc
Caribou Biosciences Inc (CRBU) Option Chain
As of September 25, 2026, Caribou Biosciences Inc is trading at $1.23, a -0.81% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 198.4%. IV Rank is 73%.
Read more
Tracking the CRBU option chain helps you see every strike and expiry on Caribou Biosciences Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Caribou Biosciences Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of CRBU options activity at a glance. Use our scanner to monitor the CRBU option chain in real time and filter for the CRBU options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For CRBU stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the CRBU option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where CRBU stock options are being actively traded and where they are not.
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy for the treatment of relapsed or refractory multiple myeloma. The company also develops CB-012, an allogeneic anti-CD371 CAR-T cell therapy for the treatment of relapsed or refractory acute myeloid leukemia; and CB-020, an allogeneic CAR-NK cell therapy for the treatment of solid tumors.
It has collaboration with AbbVie Manufacturing Management Unlimited Company to develop CAR-T cell therapies. The company was incorporated in 2011 and is headquartered in Berkeley, California.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Caribou Biosciences Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen CRBU options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of CRBU stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile77.38% Elevated
- Market cap (M$)132
- 52 weeks high-65.25%
- 52 weeks low0.82%
- Analyst recommendationStrong Buy
1.00 - Target price$12.00
875.61% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-11
- P/E—
- Future P/E—
- EPS (ttm)-1.08
- EPS growth next 5 years-2.05%
As of September 25, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 20.61 | 150 | 0 | 0.07 | 0.73 | 0.30 | 1.30 | 0.50 | -59.68 | — | 0.05 | 0.00 | 0.05 | 0 | 17 | 79.39 |
| 53.71 | 182 | 0 | 0.47 | 0.23 | — | 0.70 | 1.00 | -19.35 | — | 0.30 | 0.00 | 0.30 | 0 | 0 | 46.29 |
| 73.48 | 137 | 0 | 0.05 | 0.00 | — | 0.05 | 1.50 | +20.97 | 0.05 | 1.05 | 0.27 | 0.28 | 0 | 146 | 26.52 |
| 84.28 | 1,364 | 0 | 0.15 | 0.00 | — | 0.15 | 2.00 | +61.29 | 0.10 | 1.05 | 0.77 | -0.20 | 0 | 514 | 15.72 |
| 90.32 | 1,209 | 0 | 0.05 | 0.00 | — | 0.05 | 2.50 | +101.61 | 0.75 | 1.75 | 1.27 | -0.02 | 0 | 10 | 9.68 |
As of September 25, 2026
Scan the full option chain in one place
Browse the full CRBU option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→